Development of a lipid-rich, soft plaque in rabbits, monitored by histology and intravascular ultrasound

Atherosclerosis

Volumn 156, Issue 2, 2001, Pages 277-287

  Chiesa, G ^a   Di Mario, C ^b   Colombo, N ^a   Vignati, L ^a   Marchesi, M ^a   Monteggia, E ^a   Parolini, C ^a   Lorenzon, P ^c   Laucello, M ^c   Lorusso, V ^c   Adamian, M ^b   Franceschini, G ^a   Newton, R ^d   Sirtori, C R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c Bracco SpA   (Italy)

^d Esperion Therapeutics Inc   (United States)

Author keywords

Animal model; Atherosclerosis; Intravascular ultrasound; Rabbit

Indexed keywords

LIPID;

ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LESION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL CALCIFICATION; CELL DEATH; CELL INFILTRATION; CHOLESTEROL DIET; COMMON CAROTID ARTERY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ELECTRIC INJURY; HISTOPATHOLOGY; INTIMA; INTRAVASCULAR ULTRASOUND; MACROPHAGE; MACROPHAGE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RELIABILITY;

ANALYSIS OF VARIANCE; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; CHOLESTEROL, DIETARY; CULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; LIPIDS; MALE; PROBABILITY; RABBITS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0035013121     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00655-9     Document Type: Article

References (40)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The scandinavian simvastain survival study (4S)
2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
3. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
4. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
5. Coronary plaque disruption
6. Plaque rupture, thrombosis, and therapeutic implications
7. Pathophysiology of plaque rupture and the concept of plaque stabilization
8. Plaque disruption and coronary thrombosis: New insight into pathogenesis and prevention
9. Lipid-lowering interventions in angiographic trials
10. Anatomic and physiologic heterogeneity in patients with syndrome X: An intravascular ultrasound study
11. Angiographically silent atherosclerosis detected by intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: Correlation with high density lipoproteins
12. Identification of coronary thrombus after myocardial infarction by intracoronary ultrasound compared with histology of tissues samples by atherectomy
13. Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound
14. Endothelial dysfunction in the early stage of atherosclerosis precedes appearnce of intimal lession assessable with intravascular ultrasound
15. Intravascular ultrasound and magnetic resonance imaging in the assessment of atherosclerotic lesions in rabbit aorta
16. Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model
17. Ischemia-related lesion characteristics in patients with stable or unstable angina: A study with intracoronary angioscopy and ultrasound
18. Comparison of coronary luminal quantification obtained from intracoronary ultrasound and both geometric and videodensitometric quantitative angiography before and after balloon angioplasty and directional atherectomy
19. Vascular would healing and neointima formation induced by perivascular electric injury in mice
20. Atherosclerotic coronary lesions with inadequate compensatory enlargement have smaller plaque and vessel volumes: Observations with three dimensional intravascular ultrasound in vivo
21. Lipid-lowering drugs: Who gets what?
22. Matrix metalloproteinases and cardiovascular disease
23. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction
24. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study
25. Cryodamage of the vessel wall accelerates the development of atherosclerotic lesions in arterial vessels of Watanabe hyperlipidemic rabbits
26. Dietary and mechanically induced rabbit iliac-femoral atherosclerotic lesions: A chemical and morphologic evaluation
27. Animal model that mimics atherosclerotic plaque rupture
28. Magnetic resonance images lipid, fibrous, calcified hemorragic, and thrombotic components of human atherosclerosic in vivo
29. High-resolution intravascular magnetic resonance imaging: Monitoring of plaque formation in heritable hyperlipidemic rabbits
30. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis
31. The unstable atheroma
32. Quantification of intramural calcification in coronary intravascular ultrasound images with automated image analysis
33. Atherosclerotic plaque caps are locally weakened when macrophage density is increased
34. Macrophage infiltration in acute coronary syndromes: Implications for plaque rupture
35. Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage, and smooth muscle cell content
36. Highly localized arterial remodeling in patients with coronary atherosclerosis. An intravascular ultrasound study
37. Morphological characteristics of clinically significant coronary artery stenosis in stable angina
38. Animals models in atherosclerosis research
39. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbits): Incidence and development of atherosclerosis and xanthoma
40. Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo